145 related articles for article (PubMed ID: 31851922)
21. Apurinic/apyrimidinic endonuclease 1 (APE1) is dispensable for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation in the immunoglobulin gene.
Islam H; Kobayashi M; Honjo T
Int Immunol; 2019 Jul; 31(8):543-554. PubMed ID: 30877298
[TBL] [Abstract][Full Text] [Related]
22. Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin Smu region: implication of AID involvement in a common step of class switch recombination and somatic hypermutation.
Nagaoka H; Muramatsu M; Yamamura N; Kinoshita K; Honjo T
J Exp Med; 2002 Feb; 195(4):529-34. PubMed ID: 11854365
[TBL] [Abstract][Full Text] [Related]
23. Why does somatic hypermutation by AID require transcription of its target genes?
Storb U
Adv Immunol; 2014; 122():253-77. PubMed ID: 24507160
[TBL] [Abstract][Full Text] [Related]
24. A source of the single-stranded DNA substrate for activation-induced deaminase during somatic hypermutation.
Wang X; Fan M; Kalis S; Wei L; Scharff MD
Nat Commun; 2014 Jun; 5():4137. PubMed ID: 24923561
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of the FACT complex, as well as histone H3.3, serves as a target marker for somatic hypermutation.
Aida M; Hamad N; Stanlie A; Begum NA; Honjo T
Proc Natl Acad Sci U S A; 2013 May; 110(19):7784-9. PubMed ID: 23610419
[TBL] [Abstract][Full Text] [Related]
26. AID targeting in antibody diversity.
Pavri R; Nussenzweig MC
Adv Immunol; 2011; 110():1-26. PubMed ID: 21762814
[TBL] [Abstract][Full Text] [Related]
27. Restriction of AID activity and somatic hypermutation by PARP-1.
Tepper S; Mortusewicz O; Członka E; Bello A; Schmidt A; Jeschke J; Fischbach A; Pfeil I; Petersen-Mahrt SK; Mangerich A; Helleday T; Leonhardt H; Jungnickel B
Nucleic Acids Res; 2019 Aug; 47(14):7418-7429. PubMed ID: 31127309
[TBL] [Abstract][Full Text] [Related]
28. A Model of Somatic Hypermutation Targeting in Mice Based on High-Throughput Ig Sequencing Data.
Cui A; Di Niro R; Vander Heiden JA; Briggs AW; Adams K; Gilbert T; O'Connor KC; Vigneault F; Shlomchik MJ; Kleinstein SH
J Immunol; 2016 Nov; 197(9):3566-3574. PubMed ID: 27707999
[TBL] [Abstract][Full Text] [Related]
29. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
[TBL] [Abstract][Full Text] [Related]
30. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
[TBL] [Abstract][Full Text] [Related]
31. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.
Martin A; Bardwell PD; Woo CJ; Fan M; Shulman MJ; Scharff MD
Nature; 2002 Feb; 415(6873):802-6. PubMed ID: 11823785
[TBL] [Abstract][Full Text] [Related]
32. The Use of Somatic Hypermutation for the Affinity Maturation of Therapeutic Antibodies.
Bowers PM; Boyle WJ; Damoiseaux R
Methods Mol Biol; 2018; 1827():479-489. PubMed ID: 30196512
[TBL] [Abstract][Full Text] [Related]
33. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
Lindley RA; Hall NE
Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
[TBL] [Abstract][Full Text] [Related]
34. Somatic mutation patterns at Ig and Non-Ig Loci.
Steele EJ; Franklin A; Lindley RA
DNA Repair (Amst); 2024 Jan; 133():103607. PubMed ID: 38056368
[TBL] [Abstract][Full Text] [Related]
35. Analysis of 6912 unselected somatic hypermutations in human VDJ rearrangements reveals lack of strand specificity and correlation between phase II substitution rates and distance to the nearest 3' activation-induced cytidine deaminase target.
Ohm-Laursen L; Barington T
J Immunol; 2007 Apr; 178(7):4322-34. PubMed ID: 17371989
[TBL] [Abstract][Full Text] [Related]
36. Nucleosome stability dramatically impacts the targeting of somatic hypermutation.
Kodgire P; Mukkawar P; North JA; Poirier MG; Storb U
Mol Cell Biol; 2012 May; 32(10):2030-40. PubMed ID: 22393257
[TBL] [Abstract][Full Text] [Related]
37. Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation.
Inlay MA; Gao HH; Odegard VH; Lin T; Schatz DG; Xu Y
J Immunol; 2006 Jul; 177(2):1146-51. PubMed ID: 16818772
[TBL] [Abstract][Full Text] [Related]
38. Efficient Induction of Ig Gene Hypermutation in Ex Vivo-Activated Primary B Cells.
Liu J; Xiong E; Zhu H; Mori H; Yasuda S; Kinoshita K; Tsubata T; Wang JY
J Immunol; 2017 Nov; 199(9):3023-3030. PubMed ID: 28939756
[TBL] [Abstract][Full Text] [Related]
39. Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.
Ouadani H; Ben-Mustapha I; Ben-Ali M; Larguèche B; Jovanic T; Garcia S; Arcangioli B; Elloumi-Zghal H; Fathallah D; Hachicha M; Masmoudi H; Rougeon F; Barbouche MR
Mol Immunol; 2016 Nov; 79():77-82. PubMed ID: 27716525
[TBL] [Abstract][Full Text] [Related]
40. Bcl6 Is Required for Somatic Hypermutation and Gene Conversion in Chicken DT40 Cells.
Williams AM; Maman Y; Alinikula J; Schatz DG
PLoS One; 2016; 11(2):e0149146. PubMed ID: 26900682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
